Registration number: SC246885

Browns Pharmacy Healthcare Limited

Contents

Company Information	1
Statement of Financial Position	2 to 3
Notes to the Unaudited Financial Statements	4 to 10

Browns Pharmacy Healthcare Limited

Company Information

Directors

Mrs Lindsay Brown Mr Gordon Brown

Registered office

6 Atholl Crescent PERTH PH1 5JN

Accountants

Morris & Young Chartered Accountants 6 Atholl Crescent PERTH PH1 5JN

Browns Pharmacy Healthcare Limited

(Registration number: SC246885)
Statement of Financial Position as at 31 March 2025

	Note	2025 £	2024 £
Fixed assets
Intangible assets	4	449,625	490,500
Tangible assets	5	755,932	811,112
		1,205,557	1,301,612
Current assets
Stocks	6	172,207	162,842
Debtors	7	695,779	621,459
Cash at bank and in hand		540,794	508,716
		1,408,780	1,293,017
Creditors: Amounts falling due within one year	8	(617,602)	(565,287)
Net current assets		791,178	727,730
Total assets less current liabilities		1,996,735	2,029,342
Creditors: Amounts falling due after more than one year	8	(250,978)	(286,758)
Provisions for liabilities		(83,681)	(97,460)
Net assets		1,662,076	1,645,124
Capital and reserves
Called up share capital	9	1,000	1,000
Retained earnings		1,661,076	1,644,124
Shareholders' funds		1,662,076	1,645,124

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Browns Pharmacy Healthcare Limited

(Registration number: SC246885)
Statement of Financial Position as at 31 March 2025

Approved and authorised by the Board on 22 December 2025 and signed on its behalf by:
 

......................................... Mr Gordon Brown Director

Browns Pharmacy Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1	General information

The company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
6 Atholl Crescent
PERTH
PH1 5JN

These financial statements were authorised for issue by the Board on 22 December 2025.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated. Details of the transition to FRS 102 are disclosed at note 14.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Fixtures & Fittings	25% reducing balance or 10% straight line
Computer Equipment	33% straight line
Motor Vehicles	25% reducing balance
Land and Buildings Freehold	nil

Browns Pharmacy Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life.

Amortisation

Goodwill, being the amounts paid in connection with the acquisition of the business, is being amortised evenly over its estimated useful life of of twenty years.

Asset class	Amortisation method and rate
Goodwill	Evenly over 20 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price.

Browns Pharmacy Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 30 (2024 - 30).

Browns Pharmacy Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4	Intangible assets

	Goodwill  £	Total £
Cost or valuation
At 1 April 2024	817,500	817,500
At 31 March 2025	817,500	817,500
Amortisation
At 1 April 2024	327,000	327,000
Amortisation charge	40,875	40,875
At 31 March 2025	367,875	367,875
Carrying amount
At 31 March 2025	449,625	449,625
At 31 March 2024	490,500	490,500

5	Tangible assets

	Land and buildings £	Furniture, fittings and equipment  £	Motor vehicles  £	Total £
Cost or valuation
At 1 April 2024	432,623	735,180	37,236	1,205,039
Additions	-	1,258	5,900	7,158
Disposals	-	-	(8,621)	(8,621)
At 31 March 2025	432,623	736,438	34,515	1,203,576
Depreciation
At 1 April 2024	11,349	360,926	21,652	393,927
Charge for the year	65	56,183	5,131	61,379
Eliminated on disposal	-	-	(7,662)	(7,662)
At 31 March 2025	11,414	417,109	19,121	447,644
Carrying amount
At 31 March 2025	421,209	319,329	15,394	755,932
At 31 March 2024	421,274	374,254	15,584	811,112

Browns Pharmacy Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Included within the net book value of land and buildings above is £421,209 (2024 - £421,274) in respect of freehold land and buildings.
 

6

Stocks

	2025 £	2024 £
Other inventories	172,207	162,842

7

Debtors

	2025 £	2024 £
Trade debtors	338,640	301,804
Prepayments	33,753	33,620
Other debtors	323,386	286,035
	695,779	621,459

Browns Pharmacy Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

8

Creditors

Creditors: amounts falling due within one year

	Note	2025 £	2024 £
Due within one year
Loans and borrowings		48,464	48,464
Trade creditors		388,982	340,586
Taxation and social security		69,057	12,745
Accruals and deferred income		106,777	96,133
Other creditors		4,322	67,359
		617,602	565,287

Creditors: amounts falling due after more than one year

	Note	2025 £	2024 £
Due after one year
Loans and borrowings		250,978	286,758

9	Share capital

Allotted, called up and fully paid shares

	2025		2024
	No.	£	No.	£
Ordinary of £1 each	1,000	1,000	1,000	1,000

Browns Pharmacy Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

10	Related party transactions

2025	At 1 April 2024 £	Advances to director £	Repayments by director £	At 31 March 2025 £
Mr Gordon Brown
Directors loan	61,987	(205,856)	114,000	(29,869)

2024	At 1 April 2023 £	Advances to director £	Repayments by director £	At 31 March 2024 £
Mr Gordon Brown
Directors loan	51,294	(104,307)	115,000	61,987

11	Parent and ultimate parent undertaking

The ultimate controlling party is Gordon Brown.